Young M R, Wright M A, Matthews J P, Malik I, Prechel M
Research Service, Hines Veterans Affairs Hospital, Hines, IL 60141, USA.
J Immunol. 1996 Mar 1;156(5):1916-22.
Production of high levels of granulocyte-macrophage CSF (GM-CSF) by LLC-LN7 tumors results in myelopoietic stimulation and an increase in cells having natural suppressor (NS) activity. Prior studies showed these NS cells could be isolated from the bone marrow of tumor-bearing mice with an Ab (ER-MP12) that recognized GM-progenitor cells. The present study showed these cells to also be in the spleen, lymph node, and tumor, and that treatment of tumor-bearing mice with low doses of IFN-gamma plus TNF-alpha reduced the frequency of E-MP12+ cells. Studies focused on characterizing the intratumoral ER-MP12+ cells and the mechanism by which they suppress T cell proliferation. When isolated and seeded in soft agar with CSF-containing LLC-LN7 supernatants, the ER-MP12+ cells grew into colonies, most of which contained both granulocytic and monocytic cells. Tumor-derived ER-MP12+ cells and their culture supernatants were suppressive to T cell proliferation. Among the factors produced by ER-MP12+ cells were TGF-beta, nitric oxide (NO), IL-10, and prostaglandin E2 (PGE2). However, it was TGF-beta and NO that mediated the suppression of T cell proliferation by ER-MP12+ cells. Intratumoral ER-MP12+ cells could be maintained as suppressive blastlike cells for at least 4 days in cultures containing CSFs, but adding IFN-gamma plus TNF-alpha to these cultures caused their differentiation mainly into nonsuppressive TNF-alpha-secreting monocytic cells. These results show that intratumoral ER-MP12+ cells having homology to GM-progenitor cells suppress T cell function by producing TGF-beta and NO. IFN-gamma/TNF-alpha treatment stimulates their differentiation and shift from production of TGF-beta and NO to production of TNF-alpha.
LLC-LN7肿瘤产生高水平的粒细胞-巨噬细胞集落刺激因子(GM-CSF)会导致骨髓造血刺激以及具有天然抑制(NS)活性的细胞增加。先前的研究表明,这些NS细胞可以用识别GM祖细胞的抗体(ER-MP12)从荷瘤小鼠的骨髓中分离出来。本研究表明这些细胞也存在于脾脏、淋巴结和肿瘤中,并且用低剂量的干扰素-γ加肿瘤坏死因子-α治疗荷瘤小鼠会降低E-MP12 +细胞的频率。研究重点是表征肿瘤内ER-MP12 +细胞及其抑制T细胞增殖的机制。当分离并接种在含有CSF的LLC-LN7上清液的软琼脂中时,ER-MP12 +细胞会长成集落,其中大多数集落同时含有粒细胞和单核细胞。肿瘤来源的ER-MP12 +细胞及其培养上清液对T细胞增殖具有抑制作用。ER-MP12 +细胞产生的因子包括转化生长因子-β(TGF-β)、一氧化氮(NO)、白细胞介素-10(IL-10)和前列腺素E2(PGE2)。然而,介导ER-MP12 +细胞对T细胞增殖抑制作用的是TGF-β和NO。在含有CSF的培养物中,肿瘤内ER-MP12 +细胞可以作为具有抑制作用的母细胞样细胞维持至少4天,但向这些培养物中添加干扰素-γ加肿瘤坏死因子-α会导致它们主要分化为不具有抑制作用的分泌肿瘤坏死因子-α的单核细胞。这些结果表明,与GM祖细胞具有同源性的肿瘤内ER-MP12 +细胞通过产生TGF-β和NO来抑制T细胞功能。干扰素-γ/肿瘤坏死因子-α治疗刺激它们的分化,并从产生TGF-β和NO转变为产生肿瘤坏死因子-α。